Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Schwabl

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Plos One|November 25, 2015
The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV CoinfectionBernhard Scheiner, Mattias Mandorfer, Philipp Schwabl, et al.
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Wiener Klinische Wochenschrift|June 20, 2018
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic functionBernhard Scheiner, Paul René Stammet, Sebastian Pokorny, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 3, 2020
Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver diseaseBenedikt Simbrunner, Rodrig Marculescu, Bernhard Scheiner, et al.
JHEP Reports : Innovation in Hepatology|March 6, 2023
Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver diseaseLorenz Balcar, Julia Krawanja, Bernhard Scheiner, et al.
Alimentary Pharmacology & Therapeutics|April 21, 2026
Correlation of Bile Acid Dynamics to Bulevirtide Response and Disease Severity in Patients With Hepatitis DMarlene Hintersteininger, Michael Schwarz, Philipp Schwabl, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 20, 2021
The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varicesRafael Paternostro, Jeannette Becker, Benedikt Silvester Hofer, et al.
Journal of Viral Hepatitis|March 11, 2022
The 'Viennese epidemic' of acute HCV in the era of direct-acting antiviralsDavid Chromy, David J M Bauer, Benedikt Simbrunner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 8, 2020
Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertensionRafael Paternostro, Constanze Bardach, Benedikt S Hofer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2022
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related CirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Plos One|November 25, 2015
The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV CoinfectionBernhard Scheiner, Mattias Mandorfer, Philipp Schwabl, et al.
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Wiener Klinische Wochenschrift|June 20, 2018
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic functionBernhard Scheiner, Paul René Stammet, Sebastian Pokorny, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 3, 2020
Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver diseaseBenedikt Simbrunner, Rodrig Marculescu, Bernhard Scheiner, et al.
JHEP Reports : Innovation in Hepatology|March 6, 2023
Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver diseaseLorenz Balcar, Julia Krawanja, Bernhard Scheiner, et al.
Alimentary Pharmacology & Therapeutics|April 21, 2026
Correlation of Bile Acid Dynamics to Bulevirtide Response and Disease Severity in Patients With Hepatitis DMarlene Hintersteininger, Michael Schwarz, Philipp Schwabl, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 20, 2021
The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varicesRafael Paternostro, Jeannette Becker, Benedikt Silvester Hofer, et al.
Journal of Viral Hepatitis|March 11, 2022
The 'Viennese epidemic' of acute HCV in the era of direct-acting antiviralsDavid Chromy, David J M Bauer, Benedikt Simbrunner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 8, 2020
Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertensionRafael Paternostro, Constanze Bardach, Benedikt S Hofer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2022
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related CirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, et al.
Pageof 15